Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353

1.

Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic.

Tuech JJ, Gangloff A, Di Fiore F, Michel P, Brigand C, Slim K, Pocard M, Schwarz L.

J Visc Surg. 2020 Mar 31. pii: S1878-7886(20)30070-9. doi: 10.1016/j.jviscsurg.2020.03.008. [Epub ahead of print]

PMID:
32249098
2.

Differentiation of cancer cells upregulates HLA‑G and PD‑L1.

Ullah M, Meziani S, Shah S, Kaci R, Pimpie C, Pocard M, Mirshahi M.

Oncol Rep. 2020 Apr 1. doi: 10.3892/or.2020.7572. [Epub ahead of print]

PMID:
32236615
3.

Development and internal validation of a diagnostic score for gastric linitis plastica.

Vivier-Chicoteau J, Lambert J, Coriat R, Bonnot PE, Goere D, Roche B, Dior M, Goujon G, Morgant S, Pocard M, Glehen O, Aparicio T, Gornet JM.

Gastric Cancer. 2020 Feb 26. doi: 10.1007/s10120-020-01051-x. [Epub ahead of print]

PMID:
32103376
4.

Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.

Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, de Chaisemartin C, Rivoire M, Trilling B, Jafari M, Portier G, Meunier B, Sieleznieff I, Bertrand M, Marchal F, Dubois A, Pocard M, Rullier A, Smith D, Frulio N, Frison E, Denost Q.

Lancet Gastroenterol Hepatol. 2020 Feb 7. pii: S2468-1253(19)30410-8. doi: 10.1016/S2468-1253(19)30410-8. [Epub ahead of print]

PMID:
32043980
5.

Evaluation of the CT Scan as the First Examination for the Diagnosis and Therapeutic Strategy for Acute Cholecystitis.

Martellotto S, Dohan A, Pocard M.

World J Surg. 2020 Feb 6. doi: 10.1007/s00268-020-05404-6. [Epub ahead of print]

PMID:
32030439
6.

Are the recommendations for post-operative antibiotics in patients with grade I or II acute calculous cholecystitis being applied in clinical practice?

Dembinski J, Guérin O, Slim K, Navarro F, Paquet JC, Tuech JJ, Pocard M, Mauvais F, Faucheron JL, Regimbeau JM.

HPB (Oxford). 2020 Jan 20. pii: S1365-182X(19)33184-3. doi: 10.1016/j.hpb.2019.10.2442. [Epub ahead of print]

PMID:
31974047
7.

Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients.

Aparicio T, Henriques J, Manfredi S, Tougeron D, Bouché O, Pezet D, Piessen G, Coriat R, Zaanan A, Legoux JL, Terrebone E, Pocard M, Gornet JM, Lecomte T, Lombard-Bohas C, Perrier H, Lecaille C, Lavau-Denes S, Vernerey D, Afchain P; NADEGE Investigators.

Int J Cancer. 2020 Jan 7. doi: 10.1002/ijc.32860. [Epub ahead of print]

PMID:
31912484
8.

Development of a Novel Orthotopic Primary Human Chordoma Xenograft Model: A Relevant Support for Future Research on Chordoma.

Salle H, Pocard M, Lehmann-Che J, Bourthoumieu S, Labrousse F, Pimpie C, Lemnos L, Guichard JP, Froelich S, Adle-Biassette H.

J Neuropathol Exp Neurol. 2020 Mar 1;79(3):314-324. doi: 10.1093/jnen/nlz121.

PMID:
31841164
9.

Peritoneal carcinomatosis is multifaceted, treatment requires expertise and collaboration with other health care personnel: New avenues of research are open.

Pocard M.

J Visc Surg. 2019 Dec;156(6):471-472. doi: 10.1016/j.jviscsurg.2019.09.006. Epub 2019 Oct 12. No abstract available.

PMID:
31611177
10.

Optimization of a low pressure plasma process for fabrication of a Drug Delivery System (DDS) for cancer treatment.

Baitukha A, Al-Dybiat I, Valinataj-Omran A, Pulpytel J, Pocard M, Mirshahi M, Arefi-Khonsari F.

Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110089. doi: 10.1016/j.msec.2019.110089. Epub 2019 Aug 15.

PMID:
31546399
11.

Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: A mouse model study.

Taibi A, Lo Dico R, Kaci R, Naneix AL, Malgras B, Mathonnet M, Pocard M.

Eur J Surg Oncol. 2020 Jan;46(1):160-165. doi: 10.1016/j.ejso.2019.09.008. Epub 2019 Sep 12.

PMID:
31540756
12.

Bowel obstruction due to a right paraduodenal hernia with midgut malrotation.

Peru N, Jouvin I, Pocard M.

J Visc Surg. 2019 Sep 12. pii: S1878-7886(19)30133-X. doi: 10.1016/j.jviscsurg.2019.08.008. [Epub ahead of print]

PMID:
31522910
13.

Management of colorectal peritoneal metastases: Expert opinion.

Abboud K, André T, Brunel M, Ducreux M, Eveno C, Glehen O, Goéré D, Gornet JM, Lefevre JH, Mariani P, Pinto A, Quenet F, Sgarbura O, Ychou M, Pocard M.

J Visc Surg. 2019 Oct;156(5):377-379. doi: 10.1016/j.jviscsurg.2019.08.002. Epub 2019 Aug 26.

PMID:
31466831
14.

MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma.

Sgarbura O, Gourgou S, Tosi D, Bakrin N, Bouazza N, Delaine S, De Forges H, Pocard M, Quénet F.

Pleura Peritoneum. 2019 Jun 27;4(2):20190010. doi: 10.1515/pp-2019-0010. eCollection 2019 Jun 1.

15.

Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature.

Pinto A, Pocard M.

Pleura Peritoneum. 2019 May 29;4(2):20190006. doi: 10.1515/pp-2019-0006. eCollection 2019 Jun 1. Review.

16.

Erratum to "Cephalic vein portacath placement technique" [J. Visc. Surg. 156 (2019) 239-243].

Jouvin I, Pocard M, Najah H.

J Visc Surg. 2019 Sep;156(4):371. doi: 10.1016/j.jviscsurg.2019.06.011. Epub 2019 Jul 23. No abstract available.

PMID:
31350203
17.

The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases.

Najah H, Malgras B, Dohan A, Gronnier C, Eveno C, Pocard M.

Surg Endosc. 2020 May;34(5):2040-2049. doi: 10.1007/s00464-019-06984-8. Epub 2019 Jul 18.

PMID:
31321535
18.

Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer.

Perrot-Applanat M, Vacher S, Pimpie C, Chemlali W, Derieux S, Pocard M, Bieche I.

Oncol Lett. 2019 Jul;18(1):674-686. doi: 10.3892/ol.2019.10392. Epub 2019 May 21.

19.

[CHIP and ovarian cancer].

Lécuru F, Bakrin N, Classe JM, Colombo PE, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R.

Gynecol Obstet Fertil Senol. 2019 Sep;47(9):617-618. doi: 10.1016/j.gofs.2019.06.007. Epub 2019 Jun 26. French. No abstract available.

PMID:
31252153
20.

Targeting the differentiation of gastric cancer cells (KATO‑III) downregulates epithelial‑mesenchymal and cancer stem cell markers.

Shah S, Pocard M, Mirshahi M.

Oncol Rep. 2019 Aug;42(2):670-678. doi: 10.3892/or.2019.7198. Epub 2019 Jun 12.

21.

Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients.

Honoré C, Delhorme JB, Nassif E, Faron M, Ferron G, Bompas E, Glehen O, Italiano A, Bertucci F, Orbach D, Pocard M, Quenet F, Blay JY, Carrere S, Chevreau C, Mir O, Le Cesne A; French Network for Rare Peritoneal Malignancies (RENAPE), French Sarcoma Clinical Network (NETSARC).

Surg Oncol. 2019 Jun;29:107-112. doi: 10.1016/j.suronc.2019.04.002. Epub 2019 Apr 15.

PMID:
31196472
22.

Cephalic vein portacath placement technique.

Jouvin I, Pocard M, Najah H.

J Visc Surg. 2019 Jun;156(3):239-243. doi: 10.1016/j.jviscsurg.2018.11.006. Epub 2019 May 29. No abstract available. Erratum in: J Visc Surg. 2019 Sep;156(4):371.

PMID:
31153802
23.

Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.

Sgarbura O, Hübner M, Alyami M, Eveno C, Gagnière J, Pache B, Pocard M, Bakrin N, Quénet F.

Eur J Surg Oncol. 2019 Dec;45(12):2386-2391. doi: 10.1016/j.ejso.2019.05.007. Epub 2019 May 9.

PMID:
31092362
24.

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, Rat P, Gagnière J, Lefevre JH, Courvoisier T, Kianmanesh R, Vaudoyer D, Rivoire M, Meeus P, Passot G, Glehen O; FREGAT and BIG-RENAPE Networks.

J Clin Oncol. 2019 Aug 10;37(23):2028-2040. doi: 10.1200/JCO.18.01688. Epub 2019 May 14.

PMID:
31084544
25.

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Mercier F, Dagbert F, Pocard M, Goéré D, Quenet F, Wernert R, Dumont F, Brigand C, Passot G, Glehen O; RENAPE Network.

BJS Open. 2018 Sep 27;3(2):195-202. doi: 10.1002/bjs5.97. eCollection 2019 Apr.

26.

Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review.

Pinto A, Pocard M.

Pleura Peritoneum. 2018 Dec 18;3(4):20180124. doi: 10.1515/pp-2018-0124. eCollection 2018 Dec 1. Review.

27.
28.
29.

Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study.

Van De Sande L, Graversen M, Hubner M, Pocard M, Reymond M, Vaira M, Cosyns S, Willaert W, Ceelen W.

Pleura Peritoneum. 2018 Jun 8;3(2):20180112. doi: 10.1515/pp-2018-0112. eCollection 2018 Jun 1.

30.

Post-operative wall shear stress in the superior mesenteric artery: Biomarker of long term outcome in patients with residual disease after incomplete cytoreductive surgery for pseudomyxoma peritonei.

Barral M, El Sanharawi I, Eveno C, Dohan A, Launay JM, Lo Dico R, Pocard M, Bonnin P.

Eur J Surg Oncol. 2019 Sep;45(9):1727-1733. doi: 10.1016/j.ejso.2019.03.001. Epub 2019 Mar 6.

PMID:
30871885
31.

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.

Ullah M, Azazzen D, Kaci R, Benabbou N, Pujade Lauraine E, Pocard M, Mirshahi M.

Neoplasia. 2019 Mar;21(3):331-342. doi: 10.1016/j.neo.2019.01.001. Epub 2019 Feb 22.

32.

PIPAC: 8 key points for a good practice with video.

Mariano G, Pocard M, Eveno C.

J Visc Surg. 2019 Apr;156(2):169-171. doi: 10.1016/j.jviscsurg.2019.01.006. Epub 2019 Feb 13. No abstract available.

PMID:
30770295
33.

Preoperative assessment of splenic involvement in patients with peritoneal carcinomatosis with CT and MR imaging.

Berthelin MA, Barral M, Eveno C, Rousset P, Dautry R, Pocard M, Soyer P, Dohan A.

Eur J Radiol. 2019 Jan;110:60-65. doi: 10.1016/j.ejrad.2018.11.022. Epub 2018 Nov 20.

PMID:
30599874
34.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.

Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups.

J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16.

PMID:
30554404
35.

Echo-guided percutaneous approach to the internal jugular vein for implantable portacath.

Pinto A, Pocard M.

J Visc Surg. 2019 Apr;156(2):147-151. doi: 10.1016/j.jviscsurg.2018.11.003. Epub 2018 Nov 28. No abstract available.

PMID:
30503156
36.

Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.

Rompteaux P, Gagnière J, Gornet JM, Coriat R, Baumgaertner I, Lecomte T, Afchain P, Zaanan A, Pocard M, Bachet JB, Bonichon-Lamichhane N, Bouché O, Faucheron JL, Forestier J, Lecaille C, Manfredi S, Tougeron D, Terrebonne E, Chehimi M, Villing AL, Sarda C, Legoux JL, Benamouzig R, Aparicio T.

Eur J Surg Oncol. 2019 Mar;45(3):331-335. doi: 10.1016/j.ejso.2018.11.012. Epub 2018 Nov 22.

PMID:
30501999
37.

Deloyers procedure.

Jouvin I, Pocard M, Najah H.

J Visc Surg. 2018 Dec;155(6):493-501. doi: 10.1016/j.jviscsurg.2018.10.001. Epub 2018 Nov 16. No abstract available.

PMID:
30455107
38.

The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma.

Shah S, Fourgeaud C, Derieux S, Mirshahi S, Contant G, Pimpie C, Lo Dico R, Soria J, Pocard M, Mirshahi M.

Oncotarget. 2018 Sep 18;9(73):33778-33787. doi: 10.18632/oncotarget.26042. eCollection 2018 Sep 18.

39.

Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.

Barat M, Hoeffel C, Bouquot M, Jannot AS, Dautry R, Boudiaf M, Pautrat K, Kaci R, Camus M, Eveno C, Pocard M, Soyer P, Dohan A.

Eur Radiol. 2019 Apr;29(4):2034-2044. doi: 10.1007/s00330-018-5734-2. Epub 2018 Oct 9.

PMID:
30302591
40.

Left anterolateral thoracotomy with cross-clamping of the descending thoracic aorta and open cardiac massage to control massive intra-abdominal bleeding.

Peru N, Malgras B, Pocard M.

J Visc Surg. 2018 Oct;155(5):407-411. doi: 10.1016/j.jviscsurg.2018.07.007. Epub 2018 Aug 23. No abstract available.

PMID:
30146448
41.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups.

Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.

PMID:
30131104
42.

Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.

Malgras B, Gayat E, Aoun O, Lo Dico R, Eveno C, Pautrat K, Delhorme JB, Passot G, Marchal F, Sgarbura O, Ferron G, Goéré D, Andre T, Pocard M; RENAPE Network.

Ann Surg Oncol. 2018 Oct;25(11):3271-3279. doi: 10.1245/s10434-018-6631-2. Epub 2018 Jul 5.

PMID:
29978366
43.

Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.

Hammoudi N, Eveno C, Lambert J, Maillet M, Glehen O, Goere D, Lourenco N, Allez M, Aparicio T, Pocard M, Gornet JM; BIG-RENAPE working group.

Eur J Surg Oncol. 2018 Jun;44(6):799-804. doi: 10.1016/j.ejso.2018.03.006. Epub 2018 Mar 17.

PMID:
29650418
44.

Preoperative assessment of peritoneal carcinomatosis of colorectal origin.

Dohan A, Hobeika C, Najah H, Pocard M, Rousset P, Eveno C.

J Visc Surg. 2018 Sep;155(4):293-303. doi: 10.1016/j.jviscsurg.2018.01.002. Epub 2018 Mar 27. Review.

PMID:
29602696
45.

Hepatectomy increases metastatic graft and growth in an immunocompetent murine model of peritoneal metastases.

Lo Dico R, Tijeras-Raballand A, Bonnin P, Launay JM, Kaci R, Pimpie C, Malgras B, Dohan A, Lo Dico GM, Pocard M.

Eur J Surg Oncol. 2018 Jun;44(6):784-791. doi: 10.1016/j.ejso.2018.01.096. Epub 2018 Jan 31.

PMID:
29525466
46.

Preoperative detection of malignant liver tumors: Comparison of 3D-T2-weighted sequences with T2-weighted turbo spin-echo and single shot T2 at 1.5 T.

Barat M, Soyer P, Dautry R, Pocard M, Lo-Dico R, Najah H, Eveno C, Cassinotto C, Dohan A.

Eur J Radiol. 2018 Mar;100:7-13. doi: 10.1016/j.ejrad.2018.01.007. Epub 2018 Jan 11.

PMID:
29496082
47.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.

Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner JM, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S; BIG-RENAPE Group.

Ann Surg Oncol. 2018 May;25(5):1184-1192. doi: 10.1245/s10434-018-6369-x. Epub 2018 Feb 26.

48.

A late life-threatening complication of laparoscopic adjustable gastric banding.

Jouvin I, Barral M, Pocard M, Najah H.

Surgery. 2018 May;163(5):1186-1187. doi: 10.1016/j.surg.2018.01.007. Epub 2018 Feb 21. No abstract available.

PMID:
29475613
49.

Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes.

Becherirat S, Valamanesh F, Karimi M, Faussat AM, Launay JM, Pimpie C, Therwath A, Pocard M.

Transl Oncol. 2018 Apr;11(2):406-415. doi: 10.1016/j.tranon.2018.01.017. Epub 2018 Feb 20.

50.

CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer.

Pasquier J, Gosset M, Geyl C, Hoarau-Véchot J, Chevrot A, Pocard M, Mirshahi M, Lis R, Rafii A, Touboul C.

Mol Cancer. 2018 Feb 19;17(1):47. doi: 10.1186/s12943-018-0787-z.

Supplemental Content

Loading ...
Support Center